SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about updates

13 Feb 2026 Evaluate
Shilpa Medicare has informed that it has entered into a binding agreement with NXI Therapeutics AG Based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE).

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

441.05 4.80 (1.10%)
11-May-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.90
Dr. Reddys Lab 1279.75
Cipla 1338.65
Zydus Lifesciences 935.55
Lupin 2250.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×